A detailed history of Graham Capital Management, L.P. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 71,038 shares of MRVI stock, worth $360,873. This represents 0.02% of its overall portfolio holdings.

Number of Shares
71,038
Holding current value
$360,873
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.87 - $11.34 $488,031 - $805,570
71,038 New
71,038 $508,000
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $676,362 - $973,130
-25,964 Reduced 49.99%
25,975 $737,000
Q1 2022

May 16, 2022

BUY
$24.46 - $40.92 $1.08 Million - $1.8 Million
44,026 Added 556.38%
51,939 $1.83 Million
Q4 2021

Feb 14, 2022

BUY
$35.0 - $45.94 $276,955 - $363,523
7,913 New
7,913 $331,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $668M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.